Buy & Sell IQIYI Inc - ADR (IQ) – IQIYI Inc - ADR Price Today
Aura AI Summary
Key Stats
- $1.00BMarket Cap
- MediaSector
- -26.95%3M Drawdown
- $2.57BEnterprise Value
- -Dividend Yield
- 0% Buy | 100% SellTrading Activity
- 48 daysTypical Hold Time
IQIYI Inc - ADR (IQ) is currently valued at a market capitalization of $1.00B, with an enterprise value of $2.57B. Over the past 52 weeks, IQIYI Inc - ADR has traded between a low of $1.03 and a high of $2.79, highlighting its annual price range. Over the past three months, IQIYI Inc - ADR has recorded a drawdown of -26.95%, reflecting recent price volatility. On average, investors hold IQIYI Inc - ADR for approximately 48 days, indicating typical investor behavior on the platform.
About IQIYI Inc - ADR
iQIYI Inc is an online entertainment service provider in China. It is primarily engaged in providing a variety of services encompassing internet video, live broadcasting, online games, online literature, animations, e-commerce, and social media platform. The company produces original video content and distributes appealing professionally produced content, partner-generated content, and user-generated content. It also offers a diverse collection of internet video content that appeals to users from broad demographics. The company's revenue is generated from membership services and online advertising services. The company earns most of its revenue from China.
Most Recent News
Capital Link Shipping launches new CEO insights on tanker markets, maritime resilience, and capital markets.
Capital Link Shipping has expanded its Maritime Intelligence Hub with new executive insights from leaders at Scorpio Tankers, DHT Holdings, d’Amico International Shipping, and others. These discussions cover market trends in crude oil and product tan...

Centene offers voluntary staff buyouts amid major ACA membership drop
Centene, a major U.S. health insurer, has launched a voluntary separation program allowing eligible employees to apply for buyouts as it faces a significant decline in membership, especially in its Affordable Care Act (ACA) marketplace plans. Members...

US agency proposes broader Medicare coverage for heart valve device, boosting Edwards Lifesciences.
The US Centers for Medicare & Medicaid Services (CMS) proposed removing the coverage with evidence development (CED) requirement for Transcatheter Aortic Valve Replacement (TAVR) in patients with symptomatic severe aortic stenosis. CMS also suggested...
